MAGNEVIST
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Mar 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11
Data completeness
2/8 — Basic
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MAGNEVIST is an injectable diagnostic agent approved by Bayer in 2000, indicated for use in magnetic resonance imaging (MRI) contrast enhancement. The product is a small molecule gadolinium-based contrast agent used to improve visualization of internal body structures during MRI procedures.
LOE Approaching
LOE-approaching lifecycle with moderate competitive pressure (30/100) suggests shrinking commercial teams and shift toward managed decline strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (11)
Gadobutrol Magnevist-controlled Body Study
Started Jan 2010
370 enrolled
Magnetic Resonance Imaging
Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Started Nov 2008
168 enrolled
FibrosisKidney FailureRenal Insufficiency
Magnevist Post-marketing Surveillance in Japan
Started Aug 2007
2,051 enrolled
Diagnostic Imaging
Multihance Versus Magnevist in Breast MRI
Started Jul 2007
130 enrolled
Breast Cancer
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
Started Jul 2004
12 enrolled
Magnetic Resonance AngiographyPeripheral Vascular DiseasesPeripheral Arterial Diseases
Worked on MAGNEVIST at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.